Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) per Common Share (Tables)

v3.23.3
Earnings (Loss) per Common Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Common Shares Used to Calculate Basic and Diluted Earnings Per Common Share
The following table reconciles the earnings (loss) and number of common shares used to calculate basic and diluted earnings per common share attributable to the Company’s shareholders:

Three Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Basic earnings per common share:
Net income (loss) - basic $ (50,672) $ (1,231) $ (95,555) $ 23,751 
Weighted shares outstanding - basic 6,460,511  3,787,269  5,691,036  3,771,472 
Basic earnings (loss) per common share $ (7.84) $ (0.33) $ (16.79) $ 6.30 
Diluted earnings per common share:
Net income (loss) - basic $ (50,672) $ (1,231) $ (95,555) $ 23,751 
Add: Convertible Note interest expense, net of tax —  —  —  11,830 
Reverse: Change in fair value of derivative liability —  —  —  (16,370)
Net income (loss) - diluted $ (50,672) $ (1,231) $ (95,555) $ 19,211 
Weighted shares outstanding - basic 6,460,511  3,787,269  5,691,036  3,771,472 
Add: Dilutive effects of stock options and restricted stock units —  —  —  115,236 
Add: Dilutive effects of if-converted Convertible Note —  —  —  382,012 
Weighted shares outstanding - diluted 6,460,511  3,787,269  5,691,036  4,268,720 
Diluted earnings (loss) per common share $ (7.84) $ (0.33) $ (16.79) $ 4.50 
Schedule of Securities Excluded
Outstanding as of September 30,
2023 2022
Convertible notes payable 260,273 382,012
Outstanding warrants 1,218,286 1,218,286
Stock options 123,307 164,902
Restricted stock units 344,492 158,635
Common and preferred Series C warrants
Total anti-dilutive stock 1,946,358 1,923,835